Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Goodyear Tire & Rubber Co (GT) vs 22nd Century Group Inc (XXII) Price & Performance

Goodyear Tire & Rubber CoTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Goodyear Tire & Rubber Co vs 22nd Century Group Inc — how do they compare? Goodyear Tire & Rubber Co trades at $7.24 (market cap $1.94B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Goodyear Tire & Rubber Co is far larger — about 1276.3× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.

GTXXII
Market Cap
$1.94B$1.52M
Sector
Consumer CyclicalTechnology
52-Week High
$11.54$1.47K
52-Week Low
$5.58$3.90
Enterprise Value
$9.25B-$6.71M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Goodyear Tire & Rubber Co

GT trades at $7.18, up 7.81% today, with a bullish technical signal and moving average alignment. The stock shows attractive valuation ratios (P/E 4.69, P/B 0.64) but faces profitability challenges, with a net income margin of -11.64% in 2025. Recent news includes a shift to the S&P SmallCap 600 and a $1.05 billion senior notes offering. Q1 2026 earnings beat estimates, yet revenue trends are declining.

Outlook: Deep value metrics and analyst consensus target of $8.75 suggest upside, but persistent net losses, high debt, and competitive pressures pose significant risks. Investors should weigh low valuation against operational headwinds and macroeconomic sensitivity.

22nd Century Group Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Goodyear Tire & Rubber Co

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.

Read more on GT

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII